CTX-II and YKL-40 in early diagnosis and treatment evaluation of osteoarthritis.

Exp Ther Med · 2019 · PMC6307395 · PMID 30651816

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Serum CTX-II and YKL-40 concentrations showed a decreasing trend during the course of treatment.

also in 47,180 other papers

an increasing trendno p-value reported

With the growth of aging population, incidence of OA shows an increasing trend.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.